We are live on ! Find out more
HALO icon

Halozyme

167 hedge funds and large institutions have $1.56B invested in Halozyme in 2017 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 76 increasing their positions, 41 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

710% more call options, than puts

Call options by funds: $34.9M | Put options by funds: $4.3M

85% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 41

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

4% more funds holding

Funds holding: 160167 (+7)

5% more capital invested

Capital invested by funds: $1.49B → $1.56B (+$69.7M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.48% less ownership

Funds ownership: 88.71%87.22% (-1.5%)

Holders
167
Holders Change
+7
Holders Change %
+4.38%
% of All Funds
4.16%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
25
Increased
76
Reduced
41
Closed
18
Calls
$34.9M
Puts
$4.3M
Net Calls
+$30.6M
Net Calls Change
+$15.5M
Name Holding Trade Value Shares
Change
Change in
Stake
PM
176
Parametrica Management
Hong Kong
-$212K -16,367 Closed
Stifel Financial
177
Stifel Financial
Missouri
-$187K -14,600 Closed
SI
178
Stephens Inc
Arkansas
-$143K -11,000 Closed
FWM
179
Frontier Wealth Management
Missouri
-$131K -10,100 Closed
Parallax Volatility Advisers
180
Parallax Volatility Advisers
California
-$79.2K -5,929 Closed
IF
181
Ironwood Financial
Arizona
-$41K -3,150 Closed
CI
182
Cowen Inc
New York
-$26K -2,000 Closed
Simplex Trading
183
Simplex Trading
Illinois
-$20K -1,500 Closed
HMS
184
Hanseatic Management Services
New Mexico
-$1K -108 Closed
AIM
185
Acrospire Investment Management
Illinois
-$1K -100 Closed

HALO Hedge Fund Activity: Q2 2017 in Review

167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2017, worth a combined $1.56B — up 4.7% from $1.49B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new HALO positions and 18 closed out — a net gain of 7 holders — while 76 added to existing stakes and 41 trimmed.

The largest buyer was MSD Partners, adding an estimated $19.8M. The largest seller was VOYA Investment Management, cutting an estimated $20M.

  • 167 institutional investors held Halozyme (HALO) as of Q2 2017, up from 160 in Q1 2017.
  • Funds reported $1.56B of Halozyme stock for Q2 2017, up 4.7% quarter-over-quarter.
  • 25 funds opened new Halozyme positions in Q2 2017 and 18 closed out, a net change of +7 holders.
  • The largest Halozyme buyer in Q2 2017 was MSD Partners, an estimated $19.8M added.
  • The largest Halozyme seller in Q2 2017 was VOYA Investment Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2017.